Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 414

2.

E-cadherin expression in invasive urothelial carcinoma.

Sun W, Herrera GA.

Ann Diagn Pathol. 2004 Feb;8(1):17-22.

PMID:
15129905
3.

E-cadherin cell-adhesion molecule expression as a diagnostic adjunct in urothelial cytology.

Ross JS, Cheung C, Sheehan C, del Rosario AD, Bui HX, Fisher HA.

Diagn Cytopathol. 1996 Jun;14(4):310-5.

PMID:
8725130
4.

Prostate stem cell antigen is overexpressed in human transitional cell carcinoma.

Amara N, Palapattu GS, Schrage M, Gu Z, Thomas GV, Dorey F, Said J, Reiter RE.

Cancer Res. 2001 Jun 15;61(12):4660-5.

5.

E-cadherin promotes intraepithelial expansion of bladder carcinoma cells in an in vitro model of carcinoma in situ.

Bindels EM, Vermey M, van den Beemd R, Dinjens WN, Van Der Kwast TH.

Cancer Res. 2000 Jan 1;60(1):177-83.

6.

Differential expression of progression-related genes in the evolution of superficial to invasive transitional cell carcinoma of the bladder.

Izawa JI, Slaton JW, Kedar D, Karashima T, Perrotte P, Czerniak B, Grossman HB, Dinney CP.

Oncol Rep. 2001 Jan-Feb;8(1):9-15.

PMID:
11115562
7.

E-cadherin expression in plasmacytoid, signet ring cell and micropapillary variants of urothelial carcinoma: comparison with usual-type high-grade urothelial carcinoma.

Lim MG, Adsay NV, Grignon DJ, Osunkoya AO.

Mod Pathol. 2011 Feb;24(2):241-7. doi: 10.1038/modpathol.2010.187. Epub 2010 Sep 3.

9.
10.

Prognostic significance of atypical papillary urothelial hyperplasia.

Swierczynski SL, Epstein JI.

Hum Pathol. 2002 May;33(5):512-7.

PMID:
12094376
11.

Expression of classic cadherins type I in urothelial neoplastic progression.

Rieger-Christ KM, Cain JW, Braasch JW, Dugan JM, Silverman ML, Bouyounes B, Libertino JA, Summerhayes IC.

Hum Pathol. 2001 Jan;32(1):18-23.

PMID:
11172290
12.

Gene expression in the urinary bladder: a common carcinoma in situ gene expression signature exists disregarding histopathological classification.

Dyrskjøt L, Kruhøffer M, Thykjaer T, Marcussen N, Jensen JL, Møller K, Ørntoft TF.

Cancer Res. 2004 Jun 1;64(11):4040-8.

13.

E-cadherin tissue expression and urinary soluble forms of E-cadherin in patients with bladder transitional cell carcinoma.

Shi B, Laudon V, Yu S, Dong D, Zhu Y, Xu Z.

Urol Int. 2008;81(3):320-4. doi: 10.1159/000151412. Epub 2008 Oct 16.

PMID:
18931551
14.

E-cadherin expression during urothelial carcinogenesis induced by N-butyl-N-(4-hydroxybutyl) nitrosamine in rats.

Oliveira PA, Colaço A, De la Cruz LF, Lopes P, Lopes C.

J Exp Clin Cancer Res. 2006 Sep;25(3):425-32.

PMID:
17167984
15.

[Proliferative activity and p53 expression in transitional cell carcinoma of the urinary bladder].

Offner FA, Schäfer G, Hittmair A, Ofner D, Grünewald K, Weyrer K, Mattern D, Eberle J, Mikuz G, Feichtinger H.

Verh Dtsch Ges Pathol. 1993;77:241-6. Review. German.

PMID:
7511289
17.

Reciprocal expression of bcl-2 and p53 oncoproteins in urothelial dysplasia and carcinoma of the urinary bladder.

Li B, Kanamaru H, Noriki S, Yamaguchi T, Fukuda M, Okada K.

Urol Res. 1998;26(4):235-41.

PMID:
9759996
18.

Transient receptor potential vanilloid type 1 (TRPV1) expression changes from normal urothelium to transitional cell carcinoma of human bladder.

Lazzeri M, Vannucchi MG, Spinelli M, Bizzoco E, Beneforti P, Turini D, Faussone-Pellegrini MS.

Eur Urol. 2005 Oct;48(4):691-8.

PMID:
15992990
19.

Loss of human E-cadherin (ECD) correlated with invasiveness of transitional cell cancer in the renal pelvis, ureter and urinary bladder.

Wakatsuki S, Watanabe R, Saito K, Saito T, Katagiri A, Sato S, Tomita Y.

Cancer Lett. 1996 May 15;103(1):11-7.

PMID:
8616803
20.

Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases.

Guo CC, Fine SW, Epstein JI.

Am J Surg Pathol. 2006 Jul;30(7):883-91.

PMID:
16819332

Supplemental Content

Support Center